Skip to main content
. 2025 Jan 27;10(2):104106. doi: 10.1016/j.esmoop.2024.104106

Table 3.

Treatment-related adverse events

All grades
Grade 3
No. % No. %
Hematologic
 Anemia 19 63.3 1 3.3
 Neutropenia 18 60.0 10 33.3
 Leukopenia 9 30.0 6 20.0
 Thrombocytopenia 3 10.0 2 6.7
Non-hematologic
 Diarrhea 11 36.7 0 0.0
 Creatinine elevation 6 20.0 0 0.0
 Neuropathy 6 20.0 0 0.0
 Rash 5 16.7 0 0.0
 General weakness 5 16.7 0 0.0
 Nausea 4 13.3 0 0.0
 Edema 4 13.3 0 0.0
 Anorexia 4 13.3 0 0.0
 Abdominal pain 3 10.0 0 0.0
 Dyspnea 2 6.7 0 0.0
 Infection 2 6.7 0 0.0
 ALP elevation 2 6.7 0 0.0
 Cough 2 6.7 0 0.0
 Constipation 2 6.7 0 0.0
 AST elevation 2 6.7 1 3.3
 Pneumonitis 2 6.7 0 0.0
 Vomiting 2 6.7 0 0.0
 Dyspepsia 2 6.7 0 0.0
 Heartburn 2 6.7 0 0.0
 Urine discoloration 2 6.7 0 0.0
 Tumor necrosis 1 3.3 1 3.3
 Pruritus 1 3.3 0 0.0
 ALT elevation 1 3.3 0 0.0
 Back pain 1 3.3 0 0.0
 Hypertension 1 3.3 0 0.0
 Mucositis/stomatitis 1 3.3 0 0.0
 Asthenia 1 3.3 0 0.0
 Paronychia 1 3.3 0 0.0
 Fever 1 3.3 0 0.0
 Pneumothorax 1 3.3 0 0.0
 Hemorrhoid 1 3.3 0 0.0

ALP, alkaline phosphatase.